Navigation Links
Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research

New York, NY (PRWEB) September 13, 2013

Treatment rates for the 10 most prevalent chronic conditions in Brazil generally ranged between 19 percent and 40 percent, according to new findings from Kantar Health’s National Health and Wellness Survey (NHWS). The research will be presented today at the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 4th Latin America Conference in Buenos Aires.

Among the most prevalent conditions in Brazil, only hypertension had a treatment rate above 50 percent, with 68 percent of patients being treated. However, many chronic conditions, particularly psychiatric ones, had poor treatment rates despite these conditions being significantly debilitating. The most debilitating chronic conditions according to respondents to the NHWS were depression (treatment rate: 39 percent), anxiety (24 percent) and insomnia (19 percent).

“Despite the high prevalence of chronic conditions in Brazil, treatment rates are particularly poor,” said Dave Pomerantz, Senior Vice President, Kantar Health. “The exception was hypertension, which may be related to the free distribution of medicine for hypertension via the Farmacia Popular do Brasil. However, many conditions—especially psychiatric conditions—have low treatment rates despite being associated with worse patient outcomes, meaning that, from a public health perspective, it’s imperative to place more emphasis on the proper management of chronic diseases in Brazil.”

Visit Kantar Health’s website to download the full poster, “Societal Unmet Needs in Brazil: Examining Prevalence, Treatment Rates and Health Outcomes.”

About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2011 and 2012 Brazil NHWS, a nationally representative, self-administered survey conducted annually. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.

Kantar Health conducts the NHWS in the U.S., Europe, Asia and Latin America. The survey is the largest self-reported dataset in the healthcare industry.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Exposure/ritual prevention therapy boosts antidepressant treatment of OCD
2. Refractory Hematological Malignances Treatment Opportunities Discussed in MP Advisors Report Published at
3. Study suggests antioxidant treatment may help NF1-linked behavioral issues
4. Low dose antibiotic treatment of C-difficile as effective as high dose in hospital setting
5. Brachytherapy to treat cervical cancer declines in US, treatment associated with higher survival
6. EcoBeauty Brand Lotus Moon Reformulates Skin Regen®, a Leading Organic Scar-Healing Treatment
7. Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis
8. Gulf Coast Spine Care Updates Pinched Nerve Treatment Options
9. Pregnancy Miracle Review Reveals Effective Infertility Treatment
10. Congratulations Congresswoman Maxine Waters for Being Named Co-chair of the Alzheimer’s Task Force;* Now it is Time to Broadly Implement the Treatment that Reverses and Stabilizes this Disease
11. Treatment For Ringing In The Ears
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology: